2 results
Approved WMOWill not start
The objective of Study M14-675 (Phase 3 induction) is to evaluate the efficacy and safety of upadacitinib 45 mg once daily (QD) compared to placebo in inducing clinical remission (per Adapted Mayo score) in subjects with moderately to severely…
Approved WMOCompleted
Investigation of the effect of an LPS challenge on:1. Nociceptive pain thresholds (primary endpoint);2. The expression of cell surface markers related to pain responses;3. Soluble markers related to painExploration of LPS effects on state-of-the-art…